Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Dapretto E"'
Autor:
Labianca, R. *, Sobrero, A., Isa, L., Cortesi, E., Barni, S., Nicolella, D., Aglietta, M., Lonardi, S., Corsi, D., Turci, D., Beretta, G.D., Fornarini, G., Dapretto, E., Floriani, I., Zaniboni, A.
Publikováno v:
In Annals of Oncology May 2011 22(5):1236-1242
Autor:
Cognetti, F., Di Cosimo, S., Bruzzi, P., Caprari, F., Dapretto, E., Trouiller, J-B., Valenti, R., Pronzato, P.
Publikováno v:
In Annals of Oncology September 2021 32 Supplement 5:S420-S420
Autor:
Ardizzoia, A, Arnoffi, J, Colombo, I, Villa, F, Dapretto, E, Frontini, L, Lissoni, P, Vaghi, M, Cazzaniga, M, Vigano, I, Gardani, G, Bidoli, P
The majority of NSCLC patients are elderly, with significant co-pathologies and poor PS. Twenty-five patients with advanced NSCLC were enrolled in this study between October 2002 and April 2006. Sixty percent of them were 65 or older and 48% had a po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1299::194f27e210d323a815c4b12e9a15f277
http://hdl.handle.net/10281/272114
http://hdl.handle.net/10281/272114
Autor:
Ardizzoia A, Arnoffi J, Colombo I, Villa F, Dapretto E, Frontini L, Lissoni P, Vaghi M, Cazzaniga M, Vigano I, Gardani G, Bidoli P
The majority of NSCLC patients are elderly, with significant co-pathologies and poor PS. Twenty-five patients with advanced NSCLC were enrolled in this study between October 2002 and April 2006. Sixty percent of them were 65 or older and 48% had a po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1299::2b39c1073bfed3133b8b4ccc9cc2cf74
https://hdl.handle.net/10281/401696
https://hdl.handle.net/10281/401696
Autor:
Cascinu, S., Berardi, R., Labianca, R., Siena, S., Alfredo Falcone, Aitini, E., Barni, S., Di Costanzo, F., Dapretto, E., Tonini, G., Pierantoni, C., Artale, S., Rota, S., Floriani, I., Scartozzi, M., Zaniboni, A., FOR THE ITALIAN GROUP FOR THE STUDY OF DIGESTIVE TRACT CANCER GISCAD
Publikováno v:
Università di Pisa-IRIS
Summary Background Preclinical data have suggested a synergistic effect of cetuximab combined with gemcitabine and cisplatin and clinical data have shown a substantial improvement in response and survival when gemcitabine is combined with a platinum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cc4866ad45106dba1f4399b82bd5db9
https://pubmed.ncbi.nlm.nih.gov/18177814
https://pubmed.ncbi.nlm.nih.gov/18177814
Autor:
GARDANI, GIANSTEFANO, Cerrone, R, Biella, C, Galbiati, G, Proserpio, E, Casiraghi, M, Arnoffi, J, Meregalli, M, Trabattoni, P, Dapretto, E, Giani, L, Messina, G, Lissoni, P.
AIM: The recent rediscovery of the natural traditional medical sciences has contributed to improve the treatment of the human diseases and, in particular, it has been shown that the pharmacological approach is not the only possible strategy in the tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1299::34d927bd4a3626cc808102171a0fcba1
http://hdl.handle.net/10281/29656
http://hdl.handle.net/10281/29656
Autor:
Labianca, R, Sobrero, A, Isa, L, Cortesi, E, Barni, S, Nicolella, D, Aglietta, M, Lonardi, S, Corsi, D, Turci, D, Beretta, Gd, Fornarini, G, Dapretto, E, Floriani, I, Zaniboni, A, Pessi, A, Mosconi, S, Aitini, E, Carlo, Ao, Astorre, P, Cabiddu, M, Mandala', M, Petrelli, F, Cassata, A, Ucci, G, Catalano, V, Clerico, M, D'Andrea, M, Gambi, A, Frontini, L, Gardani, G, Vaghi, M, Gridelli, C, Gottardi, O, Jirillo, A, Martignoni, G, Piazza, E, Tabiadon, D, Zagonel, V, Meriggi, F, Bolzoni, P, Naso, G. Italian Group for the Study of Gastrointestinal Cancer-GISCAD.
In advanced colorectal cancer, chemotherapy is usually administered without pauses and until progression but patients can experience cumulative toxicity and cannot tolerate a heavy therapeutic charge.The aim of the present trial was to evaluate wheth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::deb6ec4366f122687b9ad4b6a5f0cb4a
http://hdl.handle.net/11573/357420
http://hdl.handle.net/11573/357420
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.